A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/232 (2006.01) A61K 31/202 (2006.01) A61K 38/21 (2006.01) A61P 1/16 (2006.01) A61P 31/14 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2738985
Disclosed is a novel therapeutic means against interferon-resistant hepatitis C. Specifically disclosed are: a pharmaceutical composition for treating interferon--resistant hepatitis C, which is characterized by comprising at least one component selected from the group consisting of an .omega.-3 polyunsaturated fatty acid, a pharmaceutically acceptable salt of the fatty acid and an ester of the fatty acid as an active ingredient; and a method for utilizing the pharmaceutical composition.
La présente invention concerne un nouveau moyen thérapeutique contre une hépatite C résistante à linterféron. Linvention concerne spécifiquement : une composition pharmaceutique destinée au traitement dune hépatite C résistante à linterféron qui est caractérisée en ce quelle renferme au moins un composé choisi dans le groupe constitué par un acide gras polyinsaturé ?-3, un sel pharmaceutiquement acceptable de lacide gras et un ester de lacide gras en tant que principe actif ; et une méthode dutilisation de la composition pharmaceutique.
Mochida Pharmaceutical Co. Ltd.
Smart & Biggar
LandOfFree
Therapeutic agent for hepatitis c does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic agent for hepatitis c, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agent for hepatitis c will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1999945